Kurhade, Chaitanya
Zou, Jing
Xia, Hongjie http://orcid.org/0000-0002-2520-7038
Cai, Hui
Yang, Qi http://orcid.org/0000-0001-8838-6910
Cutler, Mark
Cooper, David http://orcid.org/0000-0002-4595-3943
Muik, Alexander http://orcid.org/0000-0003-4561-2273
Jansen, Kathrin U. http://orcid.org/0000-0001-5354-4202
Xie, Xuping http://orcid.org/0000-0003-0918-016X
Swanson, Kena A.
Shi, Pei‑Yong http://orcid.org/0000-0001-5553-1616
Article History
Received: 24 March 2022
Accepted: 12 May 2022
First Online: 23 June 2022
Competing interests
: X.X. and P.-Y.S. have filed a patent on the reverse genetic system of SARS-CoV-2. C.K., J.Z., H.X., X.X., and P.-Y.S. received compensation from Pfizer to perform the project. H.C., Q.Y., M.C., D.C., K.U.J., and K.A.S. are employees of Pfizer and may hold stock options. A.M. is an employee of BioNTech and may hold stock options. All other authors have no competing interests.